IX Biopharma Ltd
SGX:42C
IX Biopharma Ltd
Cash from Investing Activities
IX Biopharma Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
IX Biopharma Ltd
SGX:42C
|
Cash from Investing Activities
S$704k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Cash from Investing Activities
-$1.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Haw Par Corporation Ltd
SGX:H02
|
Cash from Investing Activities
S$258m
|
CAGR 3-Years
23%
|
CAGR 5-Years
16%
|
CAGR 10-Years
61%
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Cash from Investing Activities
-S$1.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is IX Biopharma Ltd's Cash from Investing Activities?
Cash from Investing Activities
704k
SGD
Based on the financial report for Dec 31, 2023, IX Biopharma Ltd's Cash from Investing Activities amounts to 704k SGD.